Monday, February 25, 2019 10:47:51 PM
QUOTE
"O.k. Ignore this...who would ignore this data? What intenrested stakeholder would NOT demand answeres to these questions?"
Here are the fact based answers:
1) CCTI spent $270m on this technology. Looking at the "Accumulated Deficit" number on the balance sheet. That is wrong. That is a function of derivative accounting under IFRS and US GAAP accounting. It is like looking at a balance sheet and only looking at the liabilities and not the assets. Look at the Total stockholder Deficit which is $14m. Basic accounting
2) "IP not current".... CCTI is constantly changing/upgrading each IP to extend duration of it. This is what business does. Nixon Vanderhye (one of the most respected Patent lawyers in the country and Malone Bailey our auditors and University of Wyoming after 9 months of due diligence are wrong?
3) Aiden Neary has not worked at CCTI for 10 years earning $500k per year. Aiden has been with CCTI for 5 years. Please refer to accrued liabilities line on the balance sheet to see that the COMPANY OWES Aiden a SALARY which he does not get until CCTI are revenue generating
4) Aiden is the largest shareholder and has never sold a single share.
Always look forward to having a fact based debate.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM